European Journal of Obstetrics & Gynecology and Reproductive Biology
Langerhans’ cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection
Introduction
Langerhans’ cells (LC) are the primary cells responsible for antigen processing and peptide presentation to T cells in the uterine cervix, being strategically located in lower strata of the epithelium of vulva, vagina and cervix [1], [2]. These cells represent a small population of bone marrow-derived cells, which can be histologically stained by ATPase, T6, CD1a, S100, MHC class II molecules, co-stimulatory/adhesion molecules and other markers [3]. In contrast, keratinocytes represent 95% of the cervical epithelium cells, may also present MHC class II molecules during inflammation and may provide some accessory co-stimulatory signals to T cells [3], [4].
The mean number of Langerhans’ cells is reported to be reduced in the cervix of women presenting with cervical intraepithelial neoplasia (CIN), harbouring human papillomavirus (HPV) or human immunodeficiency virus (HIV), or both [5], [6], [7]. Overall, most Langerhans’ cells constitutively express HLA class II molecules, and the expression of HLA-DQ molecules by these professional antigen-presenting cells (APCs) has been reported to be upregulated in patients presenting with high-grade squamous intraepithelial lesions (HG-SIL) related to HPV, suggesting that the increased expression of HLA-DQ molecules may be functionally related to the progression of neoplasia [8]. On the other hand, the severity of CIN has also been associated with several immunosuppressive conditions, particularly with HIV-related diseases [9], [10]. HIV-positive women without CIN exhibit increased expression of HLA-DR molecules in epithelial cervix macrophages and a decreased proportion of dendritic cells in the cervical stroma [11].
HIV-positive women have an increased risk of persistent HPV infection and genital lesions; however, the natural history of cervical neoplasia in these patients remains unclear. An inverse correlation between CD4+ cell counts and severity of cervical neoplasia has been reported in these patients, indicating the importance of these cells in local immunomodulation [12]. Despite the studies, documenting the local immune profile in SIL in the general population [13], [14], only few studies were published regarding the features of immune cells in HIV-positive women presenting with CIN, most of them evaluating the S100 protein of Langerhans’ cells [7], [15]. However, no studies have been conducted regarding the evaluation of HLA class II molecules in HPV-related cervical lesions of HIV-positive patients.
In the present study, we analysed the histological pattern of S100, and HLA class II molecule expression in cervical biopsies stratified according to HIV status, to the severity of CIN and to HPV type.
Section snippets
Sample selection
A total of 78 non-pregnant premenopausal patients, colposcopically and cytologically screened for HPV and CIN, seen at four Gynaecological Reference Outpatient Services of the State of São Paulo, Brazil, from 1996 to 2001 were studied. Forty-four HIV-negative women aged 19–50 years (median=36 years), and 34 HIV-positive women aged 19–47 years (median=29 years) were enrolled. According to CDC 1993 classification criteria [16], HIV-positive women were assigned to category 1 when their peripheral
Histopathological features
Cervical specimens collected from HIV-negative patients (n=44) showed normal histology in four cases, LG-SIL in 12 and HG-SIL in 28. Cervical biopsies from HIV-positive women (n=34) showed normal histology in six cases, LG-SIL in 17, and HG-SIL in 11.
Human papillomavirus detection and typing
Among HIV-negative women, HPV DNA was identified in 36/44 (81.8%) cases. HPV 16 was detected in 23/36 (63.9%) of these patients, nine of them (39.1%) presented LG-SIL and 14 (60.8%) HG-SIL. HPV 18 was detected in 14/23 (60.8%) of these patients,
Discussion
A higher prevalence (30–50%) of HPV DNA has been previously reported for HIV-positive women included in category 2 and 3 of CDC classification when compared to HIV-positive category 1 and HIV-negative patients [26]. The increased frequency of HPV DNA in HIV-positive women has been explained by the immunosuppression to which HIV-positive women are submitted, resulting in a more persistent HPV infection in relation to HIV-negative women. Irrespective of HIV status, HPV clearance is deficient in
Condensation
Langerhans’ cells and HLA molecules were evaluated in cervical biopsies from HIV+ and HIV− patients.
Acknowledgements
To Mrs. Ana Maria Anselmi Dorigan for excellent technical assistance. Financial support: FAPESP (97/04490-8 and 01/02908-2-MA Gonçalves).
References (43)
- et al.
Evaluation of Langerhans’ cells in the cervical epithelium of women with cervical intraepithelial neoplasia
Gynecol. Oncol.
(1999) - et al.
Quantitative assessment of Langerhans’ cells in human cervical intraepithelial neoplasia and wart virus infection
Am. J. Obstet. Gynecol.
(1986) - et al.
Langerhans’ cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection
Gynecol. Oncol.
(1993) - et al.
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study
Lancet
(2002) - et al.
Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection
Hum. Pathol.
(1996) - et al.
HIV+ patients have increased lymphocyte infiltrates in CIN lesions
Gynecol. Oncol.
(2000) - et al.
HLA-DQB1 *03 and cervical intraepithelial neoplasia type I-III
Lancet
(1993) - et al.
The antigen-presenting function of human Langerhans’ cells
Immunobiology
(1984) - et al.
Subpopulations of Langerhans’ cells in cervical neoplasia
Br. J. Obstet. Gynaecol.
(1987) - et al.
The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium
Clin. Exp. Immunol.
(1999)